31.90

1.36% -0.44

After Hours: 31.85 -0.05 -0.16%

Castle Biosciences Inc (CSTL)

Overview News Price History Option Chain Financials Why CSTL Down? Discussions Forecast

Castle Biosciences Inc stock is traded at $31.90, with a volume of 278.21K. It is down -1.36% in the last 24 hours and down -19.57% over the past month. Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Previous Close:

$32.34

Open:

$32.42

24h Volume:

278.21K

Relative Volume:

0.70

Market Cap:

$931.12M

Revenue:

$219.79M

Net Income/Loss:

$-57.47M

P/E Ratio:

-14.84

EPS:

-2.15

Net Cash Flow:

$-19.25M

1W Performance:

-1.54%

1M Performance:

-19.57%

6M Performance:

+64.94%

1Y Performance:

+14.54%

1-Day Range:

$31.39

$32.83

1-Week Range:

$31.38

$33.30

52-Week Range:

$14.59

$44.28

Castle Biosciences Inc Stock (CSTL) Company Profile

Name

Castle Biosciences Inc

Sector

Healthcare (1112)

Industry

Diagnostics & Research (52)

Phone

866-788-9007

Address

505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX

Employee

823

Twitter

@castlebio

Next Earnings Date

2024-11-04

Latest SEC Filings

CSTL's Discussions on Twitter

Compare CSTL vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CSTL Castle Biosciences Inc	31.90	943.96M	219.79M	-57.47M	-19.25M	-2.15
TMO Thermo Fisher Scientific Inc	509.82	198.06B	44.56B	6.73B	6.29B	17.74
DHR Danaher Corp	214.94	155.50B	24.57B	3.60B	5.25B	5.0475
IDXX Idexx Laboratories Inc	617.20	51.80B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	124.88	36.46B	6.95B	1.30B	1.15B	4.5696
WAT Waters Corp	319.83	32.29B	3.17B	642.63M	539.81M	10.77

Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-14-23	Initiated	Guggenheim	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-07-22	Initiated	Stephens	Overweight
Apr-30-21	Initiated	Lake Street	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-27-19	Reiterated	Canaccord Genuity	Buy
Aug-19-19	Initiated	BTIG Research	Buy
Aug-19-19	Initiated	Canaccord Genuity	Buy
Aug-19-19	Initiated	Robert W. Baird	Outperform
Aug-19-19	Initiated	SVB Leerink	Outperform

View All

Castle Biosciences Inc Stock (CSTL) Latest News

04:50 AM

Hedge Fund Bets: Will Castle Biosciences Inc stock go up in YEARDip Buying & AI Enhanced Market Trend Forecasts - baoquankhu1.vn

04:50 AM

Feb 10, 2026

Castle Biosciences stock jumps after FDA grants Breakthrough Device status to melanoma test - MSN

Feb 10, 2026

Feb 09, 2026

EV Market: Can Castle Biosciences Inc deliver alpha2025 Stock Rankings & Reliable Entry Point Trade Alerts - baoquankhu1.vn

Feb 09, 2026

Aug Weekly: Can Castle Biosciences Inc. maintain its current growth rateEarnings Overview Report & Long-Term Investment Growth Plans - baoquankhu1.vn

Feb 09, 2026

Castle Biosciences (CSTL) Loses 16.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz

Feb 09, 2026

Feb 08, 2026